AB-1002 is an investigational one-time gene therapy administered directly to the heart to promote production of a modified version (I-1c) of the naturally occurring protein inhibitor-1, designed to ...
If we keep (AI) a dark secret, they will delve into it anyway. I try to keep them safe,” said Jodi Flom Nathanson, library ...
(“Inmedix”), with its recently FDA-cleared CloudHRV ® System, was named by Fitt/Insider as one of 50 of health and wellness’s ...
HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane ...
Despite their status — thousands are U.S. citizens — they end up anywhere from foster care to their parents’ home countries ...
The Waco Riverwalk in Waco, Texas is what happens when a city decides to give its river the respect it deserves. This ...
The air inside the Greater Columbus Convention Center during the Arnold Sports Festival is usually thick with the scent of ...
Zongertinib provided substantial clinical benefit for patients with advanced or metastatic HER2-mutant advanced non-small cell lung cancer, surpassing the historical standard of care efficacy for this ...
MIT Technology Review discovered that the stealth startup’s founder John Schloendorn also pitched a startling, medically ...
US FDA clears Lantern Pharma and Starlight Therapeutics’ IND for a planned phase 1 paediatric CNS cancer trial of STAR-001: Dallas Monday, March 30, 2026, 14:00 Hrs [IST] Lanter ...
Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference. PARIS and CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ ...
Harmful products driving increases in cancer, diabetes, infertility…kids’ cheap ‘fast fashion’ may contain high levels of lead…40K heart-related deaths a year linked to colder weather…and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results